4-(6,7-dimethoxyquinazolin-4-yl)-1,4-diazepane-1-sulfonamide hydrochloride manufacturers
- Enpp-1-IN-14
-
- $51.00
-
2026-07-14
- CAS:2687222-59-7
- Purity: 99.83%
- Supply Ability: 10g
|
| | 4-(6,7-dimethoxyquinazolin-4-yl)-1,4-diazepane-1-sulfonamide hydrochloride Basic information |
| | 4-(6,7-dimethoxyquinazolin-4-yl)-1,4-diazepane-1-sulfonamide hydrochloride Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 9.62 mg/mL (23.82 mM; Need ultrasonic) | | form | Solid | | color | White to off-white |
| | 4-(6,7-dimethoxyquinazolin-4-yl)-1,4-diazepane-1-sulfonamide hydrochloride Usage And Synthesis |
| Uses | Enpp-1-IN-14 (Compound 015) is a potent Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) inhibitor with an IC50 value of 32.38 nM for recombinant human ENPP-1. Enpp-1-IN-14 has anti-tumor activity[1]. | | in vivo | Enpp-1-IN-14 (compound 015) (50 mg/kg; IP; BID, for 31 days) significantly inhibits tumor growth[1]. | Animal Model: | Female C57BL/6 mice (4-6 weeks; implanted subcutaneously with 2×105 MC38 cells)[1] | | Dosage: | 50 mg/kg | | Administration: | IP; BID, for 31 days (given a single 10 Gy exposure of focal radiation to the tumor site) | | Result: | Significantly inhibited tumor growth. |
| | References | [1] Srinivas Rao Kasibhatla, et al. Inhibitors of ectonucleotide pyrophosphatase/phosphodiesterase 1 (enpp1) and methods of use thereof. WO2021158829A1. |
| | 4-(6,7-dimethoxyquinazolin-4-yl)-1,4-diazepane-1-sulfonamide hydrochloride Preparation Products And Raw materials |
|